Bioserv America

Bioserv (also known as Bioserv America or Bioserv Corporation) was a boutique cGMP contract manufacturing organization (CMO) based in San Diego, California. Founded in 1988, the company specialized in providing aseptic and non-aseptic bulk formulation, filtration, manual and automated filling, lyophilization, and clinical packaging services. It catered to the pharmaceutical, biotechnology, medical device, and diagnostic industries, with a particular focus on handling small-to-medium batches, high-potency compounds, and antibody-drug conjugates (ADCs). Bioserv was acquired by Sorrento Therapeutics in April 2020 to support its clinical and commercial manufacturing needs, but ultimately shut down in August 2024 following Sorrento's bankruptcy and liquidation proceedings.